BUFFALO, N.Y. – Andrew H. Talal, MD, professor of medicine
at the Jacobs School of Medicine and Biomedical Sciences at the
University at Buffalo will receive a major, $7 million award to
address a casualty of the national opioid epidemic: the spread of
hepatitis C virus (HCV) among drug users who share needles.
A study led by University at Buffalo nursing researcher Carla
Jungquist reveals that the vast majority of post-operative patients
given opioid medications through intravenous infusions are not
monitored often enough to detect respiratory depression, a
potentially deadly result of overdose.
UB’s Bright Buffalo Niagara program will showcase the next
wave of entrepreneurs and promising startup companies on June 15,
and will include a keynote address by Bill Rancic, entrepreneur,
investor and winner of “The Apprentice.”